Mechanical dyssynchrony as a selection criterion for cardiac resynchronization therapy: Design of the AMEND-CRT trial

Heart Failure

Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: advancing patient selection?

Heart Rhythm

Trenson S, Kahr PC, Schwaiger JM, Betschart P, Kuster J, Vandenberk B, Duchenne J, Beela AS, Stankovic I, Voros G, Flammer AJ, Schindler M, Saguner AM, Willems R, Ruschitzka F, Steffel J, Breitenstein A, Voigt JU, Winnik S

doi: 10.1016/j.hrthm.2024.10.031

Heart Failure

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

ESC Heart Fail

García-Bolao I, Gardner RS, Gras D, D'Onofrio A, Mark G, Nair D, Lellouche N, Novak M, Lo R, Chew E, Wright D, Kaplan A, Bertini M, Veraghtert S, Harbin MM, Matznick E, Yong P, Stein KM

doi: 10.1002/ehf2.15190

Heart, Artery and Coronary Diseases

Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy

Heart Rhythm

Iwawaki T, Inden Y, Yanagisawa S, Miyamae K, Miyazawa H, Goto T, Kondo S, Tachi M, Shimojo M, Tsuji Y, Murohara T

doi: 10.1016/j.hrthm.2025.02.002

Heart, Artery and Coronary Diseases

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

J Am Heart Assoc

Shivakumar N, Friedman DJ, Fudim M, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Young J, Tang A, Olivas-Martinez A, Inoue LYT, Sanders GD, Al-Khatib SM

doi: 10.1161/JAHA.123.031785

Atrial FibrillationTherapy and Intervention

Rationale and design of the Anticoagulant Therapy after Left Atrial Appendage Closure (ATLAAC) Trial

Am Heart J

Gosvig K, Goller J, Hansson NH, Brandes A, Modrau I, Rasmussen LF, Eskesen K, Jensen AKG, Belley-Côté E, Whitlock R, Riber LPS

doi: 10.1016/j.ahj.2025.04.015

Heart, Artery and Coronary DiseasesTherapy and Intervention

Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients

Clin Res Cardiol

Kirchner J, Gerçek M, Sciacca V, Reil JC, Guckel D, Potratz M, Omran H, Friedrichs K, Eitz T, Bleiziffer S, Schramm R, Imnadze G, Sohns C, Gummert J, Rudolph V, Rudolph TK, Sommer P, Fink T

doi: 10.1007/s00392-024-02450-1

Cardiac Arrest or Death

RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study Rationale and Design

Am Heart J

Krychtiuk KA, Starks MA, Al-Khalidi HR, Mark DB, Monk L, Yow E, Kaltenbach L, Jollis JG, Al-Khatib SM, Bosworth HB, Ward K, Brady S, Tyson C, Vandeventer S, Baloch K, Oakes M, Blewer AL, Lewinski AA, Hansen CM, Sharpe E, Rea TD, Nelson RD, Sasson C, McNally B, Granger CB, RACE-CARS NC Counties

doi: 10.1016/j.ahj.2024.07.013

Heart Failure

Cardiac resynchronization therapy in acute heart failure and left bundle-branch block in a real-life registry

Colomb Med (Cali)

Aguiló O, Trullàs JC, Espinosa B, López-Ayala P, Gil V, López-Grima ML, Herrero-Puente P, Jacob J, López-Díez MP, Garrido JM, Millán J, Aguirre A, Piñera P, Müller CE, Llorens P, Miro Ò

doi: 10.25100/cm.v54i4.5850

Heart, Artery and Coronary DiseasesTherapy and Intervention

Prospective study on the impact of different anti-thrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves - The NOTION-4 trial: Anti-thrombotic therapy and TAV-HALT

Am Heart J

Thuraiaiyah J, Jørgensen TH, Jensen JM, Fuchs A, Willemen Y, Terkelsen CJ, Kofoed KF, Søndergaard L, Nørgaard B, De Backer O

doi: 10.1016/j.ahj.2024.10.002

Related content

Lateral QRS amplitude is independently associated with outcome after cardiac resynchronization therapy: advancing patient selection?

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

Decreased Left Ventricular Systolic Function during the Late Phase after Response to Cardiac Resynchronization Therapy

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis

Rationale and design of the Anticoagulant Therapy after Left Atrial Appendage Closure (ATLAAC) Trial

Mortality after cardiac resynchronization therapy or right ventricular pacing in transcatheter aortic valve replacement recipients

RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study Rationale and Design

Cardiac resynchronization therapy in acute heart failure and left bundle-branch block in a real-life registry

Prospective study on the impact of different anti-thrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves - The NOTION-4 trial: Anti-thrombotic therapy and TAV-HALT